Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective, Comparative, Randomized, Single Blind, Superior, Pivotal Study to Evaluate the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath' Compared to the Manual Rehabilitation Management(COPD, Asthma, Lung Cancer, Etc.)

NCT05299385 is registered in ClinicalTrials.gov with Lifesemantics Corp. as lead sponsor.

NCT NCT05299385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05299385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective, Comparative, Randomized, Single Blind, Superior, Pivotal Study to Evaluate the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath' Compared to the Manual Rehabilitation Management(COPD, Asthma, Lung Cancer, Etc.)
Lead sponsor
Lifesemantics Corp.
Phase
Phase 3
Overall status
Unknown status
Start date
January 13, 2022
Completion date
June 30, 2022
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

asthma copd, chronic obstructive pulmonary disease, home based rehabilitation, lung cancer, lung diseases, mobile application, pulmonary rehabilitation, rehabilitation, respiratory rehabilitation, respiratory system disease